Benefit of Metastasectomy in Renal Cell Carcinoma: A Propensity Score Analysis
2022 · Clinical Genitourinary Cancer · 14 citations
https://doi.org/10.1016/j.clgc.2022.03.010
S
Stefanie Mollnar
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
6
Papers
138
Citations
5
h-index
2
i10-index
Stefanie Mollnar is an academic researcher from Medical University of Graz. The author has contributed to research in topics: Inflammatory Biomarkers in Disease Prognosis & Cancer Immunotherapy and Biomarkers & Renal cell carcinoma treatment. The author has an h-index of 5, co-authored 6 publications.
Papers by this author
worksEstimation versus measurement of the glomerular filtration rate for kidney function assessment in patients with cancer undergoing cisplatin-based chemotherapy
2020 · Scientific Reports · 6 citations
https://doi.org/10.1038/s41598-020-68010-5
Decrease in treatment intensity predicts worse outcome in patients with locally advanced head and neck squamous cell carcinoma undergoing radiochemotherapy
2020 · Clinical & Translational Oncology · 6 citations
https://doi.org/10.1007/s12094-020-02447-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat